These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

European Hematology Association Annual Congress 2023

Frankfurt, Germany June 8 - 11, 2023

Results 1

Jun 11, 2023

Revumenib in Patients with Acute Leukemias: Compassionate Use Program Experience

Rubnitz, J, et al.

View Material